Close

Genentech's (RHHBY) TECENTRIQ Receives FDA Approval as NSCLC Treatment in Certain Patients

Go back to Genentech's (RHHBY) TECENTRIQ Receives FDA Approval as NSCLC Treatment in Certain Patients
Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) Delayed: 29.90 -0.64 (2.1%)
Previous Close $30.54    52 Week High $35.13 
Open $30.08    52 Week Low $28.10 
Day High $30.12    P/E N/A 
Day Low $29.80    EPS $0.00 
Volume 1,021,436       

Brown & Brown, Inc. (NYSE: RO) Delayed: 8.49 +0.55 (6.93%)
Previous Close $7.94    52 Week High $8.59 
Open $7.94    52 Week Low $7.82 
Day High $8.59    P/E 6.53 
Day Low $7.82    EPS $1.30 
Volume 42,732       

ROGERS CORPORATION (NYSE: ROG) Delayed: 109.33 +0.26 (0.24%)
Previous Close $109.07    52 Week High $76.55 
Open $108.79    52 Week Low $41.92 
Day High $109.57    P/E 61.77 
Day Low $108.06    EPS $1.77 
Volume 10,935